Quantification of the tumor-specific Endo II staining was performed with imaging software to generate H-scores [25], confirming that HER2+ primary tumors had significantly higher Endo II expression relative to luminal tumors (Fig. 1b). Here, ERBB2 is linked to neoplasm.